Cfm Wealth Partners LLC Gilead Sciences, Inc. Transaction History

Cfm Wealth Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$63.47 - $69.35 $218,971 - $239,257	-3,450 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $256,620 - $292,803	-4,277 Reduced 55.35%	3,450 $223,000
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $105,652 - $120,385	-1,865 Reduced 19.44%	7,727 $450,000
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $18,319 - $23,033	-295 Reduced 2.98%	9,592 $610,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $15,842 - $18,396	-219 Reduced 2.17%	9,887 $760,000
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $3,319 - $4,251	53 Added 0.53%	10,106 $756,000
Q4 2019 Jan 30, 2020	BUY	$61.62 - $67.78 $619,465 - $681,392	10,053 New	10,053 $635,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Cfm Wealth Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Cfm Wealth Partners LLC with notifications on news.